Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-Ras(V12) and Loss of p53

por Hall, Emily H., Liu, Yuan, Xiao, Aizhen, Shock, Lisa, Brautigan, David L., Mayo, Marty W., Adusumilli, Prasad S., Jones, David R.
Publicado 2014

Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia

por den Hartog, Gerco, Chattopadhyay, Ranajoy, Ablack, Amber, Hall, Emily H., Butcher, Lindsay D., Bhattacharyya, Asima, Eckmann, Lars, Harris, Paul R., Das, Soumita, Ernst, Peter B., Crowe, Sheila E.
Publicado 2016

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

por Dillon, Patrick M., Petroni, Gina R., Smolkin, Mark E., Brenin, David R., Chianese-Bullock, Kimberly A., Smith, Kelly T., Olson, Walter C., Fanous, Ibrahim S., Nail, Carmel J., Brenin, Christiana M., Hall, Emily H., Slingluff, Craig L.
Publicado 2017

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

por Patel, Sapna P, Petroni, Gina R, Roszik, Jason, Olson, Walter C, Wages, Nolan A, Chianese-Bullock, Kimberly A, Smolkin, Mark, Varhegyi, Nikole, Gaughan, Elizabeth, Smith, Kelly T, Haden, Kathleen, Hall, Emily H, Gnjatic, Sacha, Hwu, Patrick, Slingluff, Craig L
Publicado 2021

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)

por Slingluff, Jr., Craig L, Petroni, Gina R, Chianese-Bullock, Kimberly A, Wages, Nolan A, Olson, Walter C, Smith, Kelly T, Haden, Kathleen, Dengel, Lynn T, Dickinson, Anna, Reed, Caroline, Gaughan, Elizabeth M, Grosh, William W, Kaur, Varinder, Varhegyi, Nikole, Smolkin, Mark, Galeassi, Nadejda V, Deacon, Donna, Hall, Emily H
Publicado 2021

MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma

por Engelhard, Victor H, Obeng, Rebecca C, Cummings, Kara L, Petroni, Gina R, Ambakhutwala, Angela L, Chianese-Bullock, Kimberly A, Smith, Kelly T, Lulu, Amanda, Varhegyi, Nikole, Smolkin, Mark E, Myers, Paisley, Mahoney, Keira E, Shabanowitz, Jeffrey, Buettner, Nico, Hall, Emily H, Haden, Kathleen, Cobbold, Mark, Hunt, Donald F, Weiss, Geoffrey, Gaughan, Elizabeth, Slingluff, Jr, Craig L
Publicado 2020